Genus3 LLC

Genus3 LLC was paid $172K by Medicaid between Apr 2020 and Mar 2022, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 65% of everything it billed.

33Billing provider infoGENUS3 LLC
SPRING, TX 77380

33aNPI1063044097assigned 02/07/2020

33bProvider typeClinical Medical Laboratory

28Total paid$172K

24GClaims3,856

24DCodes billed5

24AFirst – last monthApr 2020 – Mar 2022

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#131 of 436

Median peer was paid$17K

This provider vs. median10.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,232	$67K
2021	2,017	$85K
2022	607	$20K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	65%	1,782	924	$111K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	22%	802	321	$38K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	12%	1,225	684	$21K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	21	18	$966.91
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	26	24	$432.19

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJOHNSON, JERRY (OWNER)

Same official

Other billing entities under JOHNSON, JERRY

Full network →

Provider	Location	Paid
Jerry L Johnson MD PA	Lufkin, TX	$3.60M
Johnson Better Care Facility, INC.	Dunn, NC	$2.35M
Jerry M Johnson Etal PTR Four Seasons Physical Therapy	Spokane, WA	$3K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.